Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.36%53.3M | -20.95%76.6M | -9.79%50.68M | 57.18%265.85M | -3.32%61.2M | 13.49%51.57M | 143.45%96.91M | 172.81%56.18M | 58.12%169.13M | 142.92%63.3M |
| Cost of revenue | -27.27%29.27M | -18.22%55.81M | -8.96%35.24M | 61.88%185.93M | -8.99%38.73M | 24.91%40.25M | 140.62%68.24M | 230.26%38.71M | 139.12%114.85M | 1,294.58%42.55M |
| Gross profit | 112.26%24.03M | -27.47%20.79M | -11.63%15.44M | 47.24%79.92M | 8.29%22.47M | -14.35%11.32M | 150.47%28.66M | 96.91%17.47M | -7.90%54.28M | -29.95%20.75M |
| Operating expense | 24.16%2.91M | -5.77%2.89M | -14.50%3.32M | -22.00%15.77M | 12.83%6.47M | -24.90%2.35M | -56.95%3.07M | -8.31%3.88M | 24.82%20.22M | -2.32%5.74M |
| Selling and administrative expenses | 13.75%4M | -3.79%3.88M | -3.13%4.45M | -15.36%19.65M | 10.46%7.51M | -16.35%3.51M | -46.05%4.04M | -3.08%4.59M | 14.46%23.22M | 4.03%6.8M |
| -Selling and marketing expense | -42.03%80K | -34.16%160K | -53.39%158K | -44.01%851K | -63.20%131K | -58.56%138K | -34.68%243K | -26.30%339K | 50.35%1.52M | 86.39%356K |
| -General and administrative expense | 16.02%3.92M | -1.85%3.72M | 0.87%4.29M | -13.35%18.8M | 14.53%7.38M | -12.72%3.38M | -46.64%3.79M | -0.58%4.26M | 12.58%21.7M | 1.55%6.44M |
| Total other operating income | -7.20%1.08M | 2.47%994K | 58.93%1.13M | 29.40%3.88M | -2.36%1.03M | 8.46%1.17M | 170.19%970K | 40.79%711K | -26.60%3M | 60.45%1.06M |
| Operating profit | 135.31%21.11M | -30.07%17.9M | -10.81%12.12M | 88.33%64.15M | 6.55%16M | -11.08%8.97M | 492.02%25.6M | 193.03%13.59M | -20.30%34.06M | -36.78%15.01M |
| Net non-operating interest income (expenses) | -0.37%-2.18M | -27.72%-2.35M | -3.64%-2.28M | 52.03%-3.35M | 592.70%2.85M | 15.25%-2.17M | 46.71%-1.84M | -57.91%-2.2M | -26.85%-6.98M | 123.63%411K |
| Non-operating interest income | -2.30%1.15M | -34.90%981K | -12.15%947K | 75.37%4.71M | 222.42%2.85M | 52.47%1.17M | 196.65%1.51M | 104.17%1.08M | 37.63%2.69M | 24.19%883K |
| Non-operating interest expense | -0.57%3.32M | -0.51%3.33M | -1.56%3.22M | -16.62%8.06M | ---- | 0.42%3.34M | -15.43%3.34M | 70.65%3.27M | 29.67%9.67M | -80.73%472K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 178.31%18.94M | -34.53%15.56M | -13.59%9.84M | 124.52%60.8M | 22.17%18.84M | -9.67%6.8M | 2,603.41%23.76M | 250.89%11.39M | -27.27%27.08M | -29.92%15.42M |
| Income tax | 405.83%4.69M | -36.22%3.73M | -10.88%2.66M | 144.13%16.58M | 87.73%6.82M | -5.02%927K | 394.92%5.84M | 198.80%2.99M | -43.49%6.79M | -49.81%3.64M |
| Net income | 142.42%14.25M | -33.98%11.83M | -14.56%7.18M | 117.96%44.22M | 1.96%12.02M | -10.36%5.88M | 6,054.49%17.92M | 274.09%8.4M | -19.54%20.29M | -20.16%11.79M |
| Net income continuous operations | 142.42%14.25M | -33.98%11.83M | -14.56%7.18M | 117.96%44.22M | 1.96%12.02M | -10.36%5.88M | 6,054.49%17.92M | 274.09%8.4M | -19.54%20.29M | -20.16%11.79M |
| Noncontrolling interests | 0.00%-1K | 0 | 0.00%-1K | 0.00%-3K | 0.00%-2K | 0.00%-1K | 0 | 0.00%-1K | 72.73%-3K | -100.00%-2K |
| Net income attributable to the company | 142.40%14.25M | -33.98%11.83M | -14.55%7.18M | 117.94%44.22M | 1.96%12.02M | -10.36%5.88M | 6,054.49%17.92M | 273.97%8.4M | -19.56%20.29M | -20.15%11.79M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 142.40%14.25M | -33.98%11.83M | -14.55%7.18M | 117.94%44.22M | 1.96%12.02M | -10.36%5.88M | 6,054.49%17.92M | 273.97%8.4M | -19.56%20.29M | -20.15%11.79M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 142.31%0.0063 | -34.18%0.0052 | -13.51%0.0032 | 117.98%0.0194 | 1.92%0.0053 | -10.34%0.0026 | 8,000.00%0.0079 | 270.00%0.0037 | -19.82%0.0089 | -20.00%0.0052 |
| Diluted earnings per share | 142.31%0.0063 | -34.18%0.0052 | -13.51%0.0032 | 117.98%0.0194 | 1.92%0.0053 | -10.34%0.0026 | 8,000.00%0.0079 | 270.00%0.0037 | -19.82%0.0089 | -19.88%0.0052 |
| Dividend per share | 0 | 0 | 0 | 0.001 | 0 | 0 | 0.001 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.